
Sign up to save your podcasts
Or
Dr. Helene Bertrand
The main interest is relieving pain. To provide pain relief she uses prolotherapy. She has published a paper on using prolotherapy for shoulder pain (PM&R 2016 January 2016). She also uses perineural injections and has invented a cream for topical pain treatment. A randomized controlled study has proven the effectiveness of this cream for pain relief (PM&R November 7 2015). She has completed a pilot study on using this cream for postherpetic neuralgia: 16 of the 20 people suffering from pain following about the shingles, on average five years previously, found relief from this cream. She is conducting a randomized placebo-controlled study using it for painful diabetic peripheral neuropathy. The study is underway with, currently, 81 of the 90 participants needed. As she has started selling the cream, the principal investigator is Dr. François Louw from Kelowna. The cream provides on average 53% pain relief (narcotics, 36%, anti-inflammatories, 23%, Tylenol 13%).
To find out more about the cream, called QR cream, go to www.qrcream.com. She has developed a new way to examine for and treat low back pain which provides 78% of those examined with pain relief using a two-minute exercise, see https://www.youtube.com/watch?v=NXNS6PNKRPo. She is about to start a randomized controlled study to assess the long-term effectiveness of this technique.
Dr. Helene Bertrand
The main interest is relieving pain. To provide pain relief she uses prolotherapy. She has published a paper on using prolotherapy for shoulder pain (PM&R 2016 January 2016). She also uses perineural injections and has invented a cream for topical pain treatment. A randomized controlled study has proven the effectiveness of this cream for pain relief (PM&R November 7 2015). She has completed a pilot study on using this cream for postherpetic neuralgia: 16 of the 20 people suffering from pain following about the shingles, on average five years previously, found relief from this cream. She is conducting a randomized placebo-controlled study using it for painful diabetic peripheral neuropathy. The study is underway with, currently, 81 of the 90 participants needed. As she has started selling the cream, the principal investigator is Dr. François Louw from Kelowna. The cream provides on average 53% pain relief (narcotics, 36%, anti-inflammatories, 23%, Tylenol 13%).
To find out more about the cream, called QR cream, go to www.qrcream.com. She has developed a new way to examine for and treat low back pain which provides 78% of those examined with pain relief using a two-minute exercise, see https://www.youtube.com/watch?v=NXNS6PNKRPo. She is about to start a randomized controlled study to assess the long-term effectiveness of this technique.